Joel Greenblatt fit · Magic Formula - ROIC alto + EV/EBIT barato
Is Xeris Biopharma Holdings, Inc. Common Stock (XERS) a Joel Greenblatt Stock?
Low Magic Formula score — expensive, low ROIC, or both.
0/100
FNo encaja
1/5 criterios cumplidos
Los criterios de Joel Greenblatt, aplicados a XERS
EBIT/EV yield ≥ 10%
clave—
ROIC ≥ 25%
clave-13.3%
EV/EBIT ≤ 12
-49.8x
Gross margin ≥ 30%
83.5%
Cómo se valora XERS en otras estrategias
Datos financieros en vivo
Cap. mercado
$1.07B
PER (TTM)
92.7x
ROIC (TTM)
12.84%
Margen bruto
81.59%
Otros análisis Joel Greenblatt
Preguntas frecuentes
What is XERS's Joel Greenblatt fit score?
XERS scores 0/100 on our Joel Greenblatt fit engine — grade F. Low Magic Formula score — expensive, low ROIC, or both.
Does Joel Greenblatt actually own XERS?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends XERS.
How often is this score updated?
XERS's Joel Greenblatt fit score is recomputed daily from the latest TTM financials.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Joel Greenblatt posea o recomiende XERS personalmente.